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Modeling human neuronal aging at a cellular level remains challenging. Human neurons are accessible from
iPSCs, but during reprogramming age-associated traits of somatic cells get lost. In this issue of Cell Stem
Cell, Mertens et al. (2015) demonstrate that neurons obtained by direct cell conversion retain age-associated
transcriptional traits and functional deficits of the donor cell population.With the advent of cellular reprogramming
topluripotency (Takahashi et al., 2007), hu-
man neurons are now broadly accessible
for the study of aspects of human neural
development, neuronal physiology, and
pathophysiology in vitro. One of the major
challenges incellulardiseasemodelingad-
dressing brain-associated disorders is,
however, that many diseases such as Alz-
heimer’s disease, Parkinson’s disease,
motor neuron diseases, or polyglutamine
disorders occur late during life and it is
speculated that age-associated changes
in neuronal physiology contribute to this
late-onset phenotype. The reprogramming
process itself results inwidespread rejuve-
nation including epigenetic remodeling
and expansion of telomeres (Lapasset
et al., 2011; Rohani et al., 2014), and it re-
mains questionable to what extent iPSC-
derived somatic cells are good models to
study age-associated disorders. In order
to produce or accelerate age-related phe-
notypes, researchers have made use of
external stressors (e.g., Koch et al., 2011)
or the overexpression of genes associated
with premature aging (Miller et al., 2013;
also reviewed in Studer et al., 2015). In
this issue of Cell Stem Cell, Mertens et al.
(2015) illustrate an alternative path by
demonstrating that directly programmed
induced neurons (iNs; Pang et al., 2011)
generated from aged donors’ fibroblasts
retain age-associated transcriptional sig-
naturesof thedonorpopulationandexhibit
functional deficits in their capacity to prop-
erly compartmentalize nuclear and cyto-
plasmatic proteins (Figure 1).
Mertens et al. first compared transcrip-
tional profiles generated by RNA
sequencing in young (<40 years of age)
versus old (>40 years of age) donor-
derivedfibroblasts and identified78genesto be significantly differentially expressed
in both groups. In line with previous data
(Lapasset et al., 2011; Rohani et al.,
2014), iPSCs derived from the same fibro-
blast populations did not reveal significant
transcriptional age-related signatures.
Next, they generated iNs (Pang et al.,
2011) by overexpressing the proneural
genes Ascl1 and Ngn2 together with a
smallmolecules cocktail to enhancedirect
conversion efficiencies (Ladewig et al.,
2012). Obtained iNs were characterized
by the expression of neuronal markers
including betaIII-tubulin or human tau,
thepresenceofNa+ andK+channel-medi-
ated inward and outward currents,
respectively, and the generation of spon-
taneous and evoked action potentials.
Interestingly, conversion efficiencies,
neuronal marker expression, and electro-
physiological properties were indistin-
guishable between iNs derived from
young or aged donor-derived fibroblasts.
Mertens et al. then purified iNs by fluo-
rescence-activated cell-sorting for the
neuronal surface antigen PSA-NCAM
and compared transcriptional profiles be-
tween young and old donor-derived iNs.
This analysis identified 202 genes to be
significantly differentially expressed in
both groups. Notably, many of these
genes have been associated with age-
related changes in the brain such as
neuronal Ca2+-homeostasis, neuron pro-
jection, or synaptic plasticity (Bishop
et al., 2010). Only seven of the genes over-
lapped with age-related changes in the fi-
broblasts indicating cell-type-specific
age-associated signatures. Finally, they
compared the transcriptional profiles of
human primary brain samples and identi-
fied an overlap of 49 genes to be differen-
tially expressed between young and oldCell Stem Cell 17,human brains and iNs derived from young
and old donors. Differential expression
of only three genes, namely LAMA3,
PCDH10, and RANBP17, was consistent
in all three cohorts included in the study,
i.e., fibroblasts, iNs, and human brains.
Among those,Mertens et al. concentrated
on RanBP17, a nuclear pore-associated
transport receptor, responsible for
proper compartmentalization of proteins
containing nuclear localization signals.
Decreased expression of RanBP17 was
confirmed in aged fibroblasts, iNs derived
thereof, and human brain samples by
quantitative polymerase chain reaction,
direct immunocytochemical detection,
and western blotting.
To address the functional conse-
quences of a decreased expression of
RanBP17, Mertens et al. developed a
reporter assay to measure nucleocyto-
plasmic compartmentalization in their
different cell systems. The reporter was
constructed in such a way that a nuclear
export signal (NES) was fused to a green
fluorescent protein (GFP) and a nuclear
import signal to a red fluorescent protein
(RFP). False localization of the two re-
porter proteins (i.e., GFP to the nucleus
and RFP to the cytoplasm) indicated a
disturbance of the nucleocytoplasmic
compartmentalization capacity of their
cellular system. Indeed, old fibroblasts
and iNs derived from aged donors’ fibro-
blasts showed significantly more false
localization of the two reporter proteins,
indicating defects in the nucleocytoplas-
mic compartmentalization of those cells.
As additional controls Mertens et al.
included an siRNA-mediated knockdown
of RanBP17 in young donor-derived iNs,
which resulted in defects in the nucleocy-
toplasmic compartmentalization similar toDecember 3, 2015 ª2015 Elsevier Inc. 637
Figure 1. Fibroblasts from Young and Aged Donors Exhibit Differential and Age-Related Profiles
During reprogramming, cells rejuvenate and iPSC-derived neurons are ‘‘young,’’ independent of the donor age. When converted directly from fibroblasts without
going via pluripotency, neurons retain age-related traits of the donor cell population. Figure produced using Servier Medical Art (http://www.servier.com).
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Previewsthose in old donor-derived iNs. Further-
more, neurons generated by expression
of Ascl1 and Ngn2 in iPSCs originating
from young and aged fibroblasts did not
display significant false localization of
the reporter constructs nor prominent
changes in gene expression (only about
5% of the identified genes were also
differentially expressed), further support-
ing the idea that reprogramming through
an intermediate pluripotent state erases
age-related signatures in the cells.
In summary, this study sheds new light
on the question of whether and to what
extent age-associated traits are main-
tained in cellular reprogramming and pro-
gramming and suggests that direct cell
fate conversion bypassing pluripotency
allows the identification of processes
associated with aging and the modeling
of human aging on a cellular level.
Besides the important contribution to the
field, the study by Mertens et al. leaves
several unanswered questions, which
provide the basis for future experiments.
One major question is about the role of
RanBP17 in human brain aging or aging
in general. In other words: ‘‘Is RanBP17
just one gene among many changed in
aged cells or tissues, or does it represent
a major ‘determinant’ or ‘master regu-
lator’ of human aging?’’ In this context,
Mertens et al. provide initial but seminal
data as siRNA-mediated knockdown of
RanBP17 resulted in subsequent changes
in the expression of 53 of the 78 genes
identified in aged fibroblasts in the same638 Cell Stem Cell 17, December 3, 2015 ª2direction, indicating that RanBP17 and
thus age-related changes in nucleocyto-
plasmic compartmentalization might act
upstream of an age-associated cascade
of cellular events. Interestingly, many
age-related neurodegenerative disorders
are associated with false localization
and subsequent aggregation of proteins
such as in the case of amyotrophic lateral
sclerosis (ALS) where the RNA binding
proteins TDP-43 or FUS translocate
from the nucleus and aggregate in the
cytoplasm. Other prominent examples
are polyglutamine-associated disorders
such as spinocerebellar ataxia type 3 or
Huntington’s disease where the cytoplas-
matic proteins Ataxin3 and Huntington,
respectively, accumulate in the nucleus.
It is tempting to speculate that an age-
associated breakdown of the nucleocyto-
plasmic compartmentalization contrib-
utes to age-dependent false localization,
thus in part explaining the fact that these
diseases occur late in life. In addition, it
needs to be defined how expression of
RanBP17 is regulated and whether rees-
tablishment of RanBP17 expression in
aged cells contributes to rejuvenation of
the cells. This result would make
RanBP17 an interesting target, both to
slow down human aging and to treat
neurodegenerative disorders. What re-
mains to be determined in detail is an un-
derstanding of how well ‘‘aged’’ iNs are
representative of ‘‘authentic’’ aged hu-
man neurons residing in the brain of
aged individuals.015 Elsevier Inc.ACKNOWLEDGMENTS
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